Mrinal M. Patnaik

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms

Anna L. Brown, H. Scott, A. Tefferi, 2023, Blood Cancer Journal.

Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia

A. Tefferi, M. Patnaik, M. Patnaik, 2016, Blood Cancer Journal.

Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML

D. Gilliland, O. Abdel-Wahab, R. Levine, 2009, Leukemia.

A three‐gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia

A. Jerez, T. Somervaille, Kiran Batta, 2023, British journal of haematology.

Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations

A. Mangaonkar, M. Patnaik, Mrinal M. Patnaik, 2023, American journal of hematology.